Sargent Investment Group’s Outset Medical OM Stock Holding History

Sargent Investment Group’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-945	Closed	-$11.4K	–	242
2024 Q4	$11.4K	Sell	945 -775	-45%	-$9.67K	﹤0.01%	234
2024 Q3	$17.5K	Hold	1,720	–	–	﹤0.01%	214
2024 Q2	$99.3K	Sell	1,720 -25	-1%	-$1.23K	0.02%	211
2024 Q1	$58.1K	Sell	1,745 -750	-30%	-$38K	0.01%	196
2023 Q4	$202K	Buy	+2,495	New	+$203K	0.04%	197

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Sargent Investment Group's OM Position: Q1 2025 in Review

Sargent Investment Group sold out of Outset Medical (OM) in Q1 2025, closing a stake of 945 shares — an estimated $11.4K sold.

Sargent Investment Group first reported a position in OM in Q4 2023 and held it in 5 quarters. The position peaked at $202K in Q4 2023. 61 funds tracked by Wall St. Rank hold OM as of Q1 2025.

Sargent Investment Group reported no remaining Outset Medical position as of Q1 2025 after selling out during the quarter.
Sargent Investment Group sold 945 Outset Medical shares in Q1 2025, an estimated $11.4K.
Sargent Investment Group first reported a position in Outset Medical in Q4 2023 and held it in 5 quarters.
Sargent Investment Group's Outset Medical position peaked at $202K in Q4 2023.
61 funds tracked by Wall St. Rank held Outset Medical as of Q1 2025.

Based on Sargent Investment Group's 13F filing for Q1 2025, filed 5 May 2025.